Research Article
Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia
Table 4
Pharmacokinetic parameters important for bioavailability of compound drug-likeness properties of selected peptides.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
†Molecular properties were calculated using SwissADME, an online tool. MW: molecular weight; HBD: number of hydrogen bond donors; HBA: number of hydrogen bond acceptors; nrotb: number of rotatable bonds; Log: the logarithm of octanol/water partition coefficient; : molar refractivity. |